Eli Lilly reports earnings Thursday. Here's what Wall Street is watching
CVS slashes profit outlook on higher medical costs, says top Aetna executive will leave
Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlook
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Your health records are coming to new apps. Here's why
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
